EMIS Acquires majority stake in pharmacy software company Rx Systems Limited

19 Aug 2010

EMIS Group plc (AIM: EMIS), the UK’s leading supplier of healthcare software to GPs, today announces that it has acquired 78.9% of the issued share capital of Rx Systems Limited (“RX”), a pharmacy software and services company, for a total consideration of up to £9.95 million.

Rx Systems has a 20.5% share of the community pharmacy market; EMIS believes that further growth in the market share can be achieved post-acquisition. 

The acquisition is an important element of EMIS’ continuing drive to provide ‘joined-up’ healthcare for NHS patients. It is anticipated that future integration of EMIS and Rx Systems technologies will enable further streamlining of electronic prescription services, benefiting patients, GPs and the 2,500 community pharmacies using Rx Systems’ ProScript dispensary management system.

Future developments will see pharmacists benefit from the link with GP practices using EMIS Access, the award winning secure online patient portal. This already allows patients to request repeat medication via internet, mobile phone or digital TV, saving time and streamlining the prescription process considerably.

There will be further advantages from interoperability between EMIS Web, EMIS’ next generation system, and ProScript. EMIS Web is currently being tested for EPS2 paired with ProScript.

Sean Riddell, EMIS CEO, said: “Rx Systems software has a strong reputation and a loyal community pharmacy customer base. Joining forces enables both EMIS and Rx Systems to identify the best way to provide GPs and pharmacists with appropriate levels of interoperability to further improve patient care and efficiencies in the prescribing environment. This means real benefits for patients, GPs and pharmacists alike.”